Market research
DVA DaVita HealthCare Partners Inc
NYSE USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 11B
- P/E ratio
- 14.73
- Analyst target
- 218.4286
- Dividend yield
- Not available
- Beta
- 0.87
Profile
Company facts
- Exchange
- NYSE
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- ISIN
- US23918K1088
- Market cap
- 11B
- P/E ratio
- 14.73
- Analyst target
- 218.4286
- Dividend yield
- Not available
- Beta
- 0.87
About
About DaVita HealthCare Partners Inc
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the DVA discussion.
5 years, 4 months ago
DaVita Inc is currently in a long term uptrend where the price is trading 9.3% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.
DaVita Inc's total revenue rose by 0.2% to $3B since the same quarter in the previous year.
Its net income has dropped by 29.0% to $174M since the same quarter in the previous year.
Finally, its free cash flow fell by 43.6% to $260M since the same quarter in the previous year.
Based on the above factors, DaVita Inc gets an overall score of 3/5.